Navigation Links
Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
Date:12/18/2007

DRNA is available at http://www.mdrnainc.com.

Nastech Forward-Looking Statements

Statements made in this press release may be forward-looking statements within the meaning of Federal Securities laws that are subject to certain risks and uncertainties and involve factors that may cause actual results to differ materially from those projected or suggested. Factors that could cause actual results to differ materially from those in forward-looking statements include, but are not limited to: (i) the ability of Nastech to obtain additional funding; (ii) the ability of Nastech to attract and/or maintain manufacturing, research, development and commercialization partners; (iii) Nastech's and/or a partner's ability to successfully complete product research and development, including preclinical and clinical studies and commercialization; (iv) Nastech's and/or a partner's ability to obtain required governmental approvals; and (v) Nastech's and/or a partner's ability to develop and commercialize products that can compete favorably with those of competitors. Additional factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements are contained in Nastech's most recent periodic reports on Form 10-K and Form 10-Q that are filed with the Securities and Exchange Commission. Nastech assumes no obligation to update and supplement forward-looking statements because of subsequent events.

Contacts:

Nastech

Ed Bell

Director, Investor Relations

(425) 908-3639

ir@nastech.com

Russo Partners, LLC

David Schull (Media)

(212) 845-4271


'/>"/>
SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Nastech to Host 2007 Analyst and Institutional Investor Day
2. Nastech to Release Third Quarter Financial Results and Host Webcast on Monday, October 29, 2007
3. Nastech Announces Third Quarter 2007 Financial Results
4. Nastech to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
5. Nastech to Present at BMO Capital Markets Focus on Healthcare Conference
6. Nastech Enters Into Feasibility Study to Develop a Non-Injectable Dosage Form of Factor IX to Control Bleeding
7. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
8. New property found in ancient mineral lodestone
9. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
10. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
11. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Formulate ... display solution for sales and marketing teams looking for a ... describes the kit as “everything you’ll need to put together ... Display Kit comes with a number of displays and accessories ... booth 20 feet by 20 feet in size. These components ...
(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...
(Date:5/20/2013)...  Dr. Gerald Zon , noted ... launched a new blog in conjunction with TriLink BioTechnologies. ... focuses on what,s trending in the field of nucleic ... discussions of research presented at conferences and meetings, reviews ... Zon (PhD Princeton University 1971) developed automated synthesis of ...
(Date:5/20/2013)... , May 20, 2013 Cempra, ... on developing differentiated antibiotics to meet critical medical ... announced that it presented data at the American ... Philadelphia demonstrating the antibacterial and ... Cempra,s prior Phase 2 clinical trial in outpatients ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2New Laboratory Temperature Controller by Oven Industries 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
... could be the basis of a new type of solar ... "We expect these structures will allow us to make better, ... investigator on the $100,000 grant. Fractals are patterns that ... silver 1-50th the width of a human hair are themselves ...
... American Botanical Council has announced that Bioforce AG is ... Investment in Phytomedicinal Research Award. Bioforce AG is a ... on pharmacological and clinical research each year, according to ... "We were surprised and honored to receive ...
... the difference between salt water and fresh water is ... ammonium bicarbonate salt solution, Penn State researchers can combine ... the salt-water fresh-water gradient to produce power anywhere. ... putting them together," said Bruce E. Logan, Kappe Professor ...
Cached Biology Technology:Bioforce Receives American Botanical Council's Tyler Award 2Bioforce Receives American Botanical Council's Tyler Award 3Bioforce Receives American Botanical Council's Tyler Award 4Bioforce Receives American Botanical Council's Tyler Award 5Unique salt allows energy production to move inland 2
(Date:5/17/2013)... Jersey, and City University of New York have invented ... effectively clears organisms to be viewed under microscopes. Visikol ... is one of the few high-quality clearing solutions currently ... Enforcement Administration (DEA) due to its use as a ... for viewing organisms under a microscope. Without them, microscope ...
(Date:5/17/2013)... Shenzhen, China---- Why Tibetan antelope can live at ... a collaborative research published in Nature Communications ... institutes provide evidence that some genetic factors may ... highland environments. The data in this work will ... and the biology of other ruminant species. , ...
(Date:5/17/2013)... American Societies for Experimental Biology (FASEB) released a new ... funding trends highlighting the devastating impact of sequestration on ... analysis follows a May 15th Senate Appropriations Committee hearing ... that the $1.6 billion cut the agency sustained in ... impact on the scientific community." , According to ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... Leading experts from the European Society on Clinical ... and the International Osteoporosis Foundation (IOF) have published ... subtrochanteric femoral (upper thigh bone) fractures and long-term ... most common drug therapy for osteoporotic fracture prevention, ...
... a warmer world? UCLA life scientists present new evidence that ... polar bears lose habitat due to global warming, these biologists ... sources of food, where they will increasingly come into competition ... competition might unfold, the UCLA biologists constructed three-dimensional computer models ...
... This Thanksgiving, when you bite into the cranberry sauce and ... comment from your sister, consider the power of sour.,Neurobiology researchers ... discovery about how some cells respond to sour tastes. ... and umami sour is arguably the strongest yet the ...
Cached Biology News:IOF and ESCEO position on atypical femoral fractures and long-term bisphosphonate use 2Biologists report more bad news for polar bears 2Biologists report more bad news for polar bears 3Biologists report more bad news for polar bears 4Sour research, sweet results 2
... printer is portable, easy-to-use and makes identifying your ... Easy to use Labels withstand ... slide sizes Time/Date stamp ... Serialization feature makes you more efficient ...
... SPA Screening Assay, 5 x ... eliminate lengthy sample extraction procedures and ... 1.32-84.28 ng/ml (4-256 pmol/ml).Sensitivity: 0.65 ng/ml ... C. Category: Drug Screening & Cellular ...
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
... C-1-tetrahydrofolate synthase, cytoplasmic ... Methylenetetrahydrofolate dehydrogenase (EC ... (EC 3.5.4.9); Formyltetrahydrofolate ... [Source:Uniprot/SWISSPROT;Acc:P11586] ...
Biology Products: